Pelvic Cancer
36
7
10
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.8%
1 terminated out of 36 trials
94.1%
+7.6% vs benchmark
3%
1 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (36)
Evaluation of On-Couch CBCT Image Quality
Evaluation of Improved Onboard Patient Imaging
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
Pediatric Oncology Recovery Trial After Surgery
Ablative Stereotactic MR-Guided Adaptive Reirradiation
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
Vaginal Dilator Therapy After Pelvic Radiation
Health Oriented Protocol for Epidermal Radiodermatitis
SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies
Reconstruction in Extended MArgin Cancer Surgery
AI as an Aid for Weekly Symptom Intake in Radiotherapy
Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.
Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy
Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.